Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged with Metal Hip Replacement

Smith & Nephew Birmingham Resurfacing premature hip failure. Many metal hip manufacturers have been under fire for the past decade over the premature failure of their metal on metal hip designs.

Smith & Nephew Birmingham Resurfacing premature hip failure

Smith & Nephew Birmingham Resurfacing premature hip failure. Smith & Nephew under fire over its BHR line of metal hip devices causing metal poisoning and pseudotumors.

Smith & Nephew Urgent Field Safety Recall Notice

The epidemic of premature metal on metal hip implant failure continues surge at an alarming rate. DePuy ASR, DePuy Pinnacle, Biomet Magnum, Smith and Nephew, Wright Conserve, Zimmer Durom cup and Stryker Rejuvenate and ABG II, are among hip replacements that continue to fail prematurely and require painful and risky revision surgery.

DePuy ASR Metallosis Injury AttorneyTotal Number of DePuy ASR Settlements Exceeds 9,400 Cases

Johnson and Johnson (J&J) and its subsidiary DePuy Orthopaedics, has agreed to add another 1,400 hip injury claims to a settlement agreement reached in 2013. This new agreement extends the deal to include recalled ASR implants that were revised as of January 31, 2015.

DePuy ASR metal on metal hip replacements continue to fail prematurely and require painful and risky revision surgery. Johnson and Johnson, the world’s largest pharmaceutical and medical device maker and its subsidiary DePuy, recently agreed to extend the settlement of its notorious line of failed metal on metal hips, to include cases where the faulty hip was replaced as of January 2015.

DePuy ASR Metallosis Injury AttorneyThis extension, provides further relieve to injured plaintiffs who were locked out of the original settlement, which cut off claims as of August 2013.

Total Number of Settlements Exceeds 9,400 Cases

On November 19,  in open federal court in Toledo, Ohio, Johnson & Johnson agreed to pay at least $2.475 billion to settle thousands of lawsuits over its recalled hip implants.

Johnson & Johnson Settlement Details

There has been many warnings issued to health departments world wide about potential problems with Smith & Nephew’s Birmingham metal-on-metal hip replacements. These hip model and others including the R3 model, have been linked to a high failure rate according to implant registry data in Europe and Australia.

metal on metal hip injury attorneySmith & Nephew recently issued a safety notice that indicates the Birmingham hip failure rate appears to be higher than 1%, which exceeds the rate established for quality standards according to the United Kingdom’s National Institute for Health and Clinical Excellence.

According to data collected since 2010 in the National Joint Registry of England and Wales, as well as the Australian Orthopaedic Associations National Joint Replacement Registry, the rate of Smith & Nephew Birmingham hip problems that were classified as a failure were 1.29% and 1.12%, respectively.

Today in open federal court in Toledo, Ohio, Johnson & Johnson agreed to pay at least $2.47 billion to settle thousands of lawsuits over its recalled hip implants. The agreement would settle about 8,000 U.S. suits against J&J’s DePuy unit brought by patients who have already had artificial hips removed. The company will pay an average of about $250,000 for each surgery and cover related medical costs.

DePuy ASR Metallosis Injury AttorneyJohnson & Johnson Under Fire from Lawsuits

The settlement is the second multibillion-dollar settlement this month for J&J. The company, agreed November 4 to pay $2.2 billion to resolve criminal and civil probes into the marketing of Risperdal and other medicines.

According to court documents, Johnson & Johnson has agreed to settle a DePuy ASR hip replacement lawsuit, on the eve of trial. The settlement agreement remains confidential.

DePuy ASR Metallosis Injury AttorneyJohnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit, the first bellwether trial in a California state court consolidation of ASR cases.

This DePuy ASR case that was set to begin later in October in California state court. See my earlier reporting on secret settlement negotiations regarding the DePuy ASR implants. This is overall good news for plaintiffs that the company is beginning to take the failure allegations seriously.

The federal judge overseeing the Biomet M2A Magnum hip failure lawsuits has denied a motion to dismiss the lawsuits based on federal preemption. Many plaintiffs have filed product liability lawsuits over early hip failure and metallosis involving the Biomet metal hip replacement device.

biomet hip recall attorneyPlaintiff Biomet Injuries

The plaintiff, Leslie Caccia, had to undergo multiple revision surgeries after his Biomet ReCap Femoral Resurfacing System and M2A-Magnum metal-on-metal hip replacement system prematurely failed.

Stryker, a well known artificial hip and medical device manufacturer, is recalling devices used in spinal surgeries. The FDA has assigned its most serious warning label to the problem, indicating that using the device could result in serious injury or death. Stryker is already under fire over lawsuits involving its Stryker Rejuvenate and ABG II artificial hips, amid allegations of early failure of the devices and the risk of metallosis. Metallosis occurs when the component parts grind against each other releasing metal ions into the bloodstream and hip joint, leading to loosening of the hip device, bone destruction, pain and swelling.

Dallas Defective Medical Device attorneyThe device is the Oasys Occipito-Cervico-Thoracic System, which is designed to stabilize the junction between the occipital bone and vertebrae in the cervical spine.

Stryker has received reports that a pin that connects the tulip head to the plate body can fracture, possibly causing blood loss, nerve injury and the need for revision surgery. The FDA put its Class I designation on the recall, a notification for potentially deadly malfunctions.

Contact Information